Bibliografía usada para elaborar el blog

La información contenida en este blog ha sido elaborada a partir de publicaciones sobre el noni, artículos científicos y resultados empíricos. De entre todos, los citados son los que siguen:

Bibliografía citada en el texto

1. Muzychkina, R.A., (1998), Natural Anthraquinones: Biological and Physiochemical Properties, Phasis, Moscow
2. Younos, C. et al, (1990), Analgesic and Behavioural Effects of Morinda Citrifolia, Planta Medica Oct.pp.430-434
3. Hiramatsu, T et al, (1993), Induction of normal phenotypes in ras-transformed cells by damnacantal from Morinda citrifolia, Cancer Letters, Sept pp 161-166
4. Tarasiuk, J. et al, (1998), The role of structural factors of anthraquinone compounds and their quinine-modified analogues in NADH dehydrogenase-catalysedoxygen radical formation, Anticancer Drug Des., Dec. pp.923-39
5. Burton, G. et al, (1994), Beta-carotene: An Unusual Type of Lipid Antioxidant, Science pp 569-573
6. Tosa, H. et al, (1998), Antraquinones from Neonauclea calycina and their inhibitory activity against DNA topoisomerase II, Biol Pharm Bull Junio pp 641-2
7. Beck, J., Barrett-Connor, E., (1971), Medical Parasitology, The C.V. Mosby Company London
8. como 7
9. como 7
10. Hilgert, I. et al, (1977) Antitumour and inmunosupressive activity of hydroxyanthraquinones and their glucosides, Folio Biol (Praha) pp 99-109.
11. p.1
12. Higuchi, H. et al, (1991), Antiretroviral activitie of anthraquinones and their inhibitory effects on reverse transcriptase. Antiviral Res. Mar-Abr. pp. 205-216
13. Anton, R. y Haag-Gerruier, M., (1980) Therapeutic use of natural anthraquinones for other than laxative action, Pharmacology 20, pp 104-112
14. Berg, W. et al, (1976) Influence of anthraquinones on the formation of urinary calculi in experimental animals, Urology A 15. pp 188-191.
15. Trease, G. y Evans, W., Pharmacognosy pp.373-401, Bailliere, Tindal, London, 1978
16. Ohkubo, T. y Shibata, M., The selective capsaicin antagonist capsazepine abolishes the anticonceptive action of eugenol and guaiacol, Sep. of Pharm, Fukuoka Dental College, Japan
17. Nishijima, H. et al, (1998) Role of endothelium and adventitia on eugenol-induced relaxation of rabbit ear artery precontracted by histamine, J Smooth Muscle Res. Jun. pp 123-137
18. Peto, R. et al, (1981) Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201-8
19. National Research Council: Diet, Nutrition & Cancer, National Academy Press, Washington DC, 1982
20. Creasey, W.A. (1985) Diet & Cancer, Lea & Febriger, Philadelphia, PA.
21. Alexander, M. et al, (1985) Oral beta-carotene can increase the number of OKT4+ cells in human blood, Immunol. Letters, 9:221-4
22. Wang, H. Ng. T. (1999) Natural products with hypoglycaemic hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities, Life sciences, pp. 2663-77
23. Tavani, A. et al, (1997) Beta-carotene intake & risk of nonfatal acute myocardial infarction in women, Eur. J. of Epidemiol. 13(6):631-7
24. Goodman, D.S., (1984) Vitamin A and retinoids in health and disease, New England journal of medicine, 310:1023-1031
25. Grundy, D., Still, C., (1985) Inhibition of acetylcolinesterases by pulegone-1,2-epoxide, oest. Biochem & Physio. 23:383-338
26. Yu, S. et al, (1994) Efficacy of beta ionone in the chemoprevention of rat mammary carcinogenesis, J. Agric. Food Chem., 56(1):41
27. Revista Itiliana Eppos, 1994, 12:5
28. Mezzetti, T.. et al, (1971) Chemistry of ursolic, Planta medica 20(3):224-252
29. Huang, M. et al, (1994) Inhibition of skin tunorigenesis by rosemary and its constituents carnosol and ursolic acid, Cancer Res. 54:701-708
30. Tokuda, H. et al, (1986) Inhibitory action of ursolic and oleanoic acid on skin tumour promotion by 12-otetradecanoylphorbol-13-acetate, Cancer letters 33:279-285
31. Kikuko, T. et al, Hair-raising cosmetic, Japanese Patent nº 05286835
32. Harry, RG. (1963) Cosmetic Materials, Their origin, characteristics and dermatological action, Chemical Publishing Co., Inc., New York
33. Kowalewski, Z. et al, (1976), Antibiotic action of betaursolic acid, Arch. Immunol. Ther. Exp. (Warsz) 24(1):11
34. Zalevota, N. et al, (1987), Preparation of some derivates of ursolic acid and their microbial activity , Chemical Ab. 106, 18867e
35. Lin, C. et al, (1990), The cytoquinetic principles of solanum incanum, J. of Nat. Prod, 53(2):513-516
36. Kashiwada, Y., (1998) Anti-AIDS agents. 30 anti-HIV activity of oleanoic acid pomolic acid and structurally related triterpenoids, J.Nat.Prod. 61(9):1090-1095
37. Tsuruga, T. et al, (1991) Biologically active constituents of melaleuca leucadendron inhibitors of induced histamine release from rat mast cells, Chem. Pharm. Bull. 39(12):3276-3278
38. Moghadasian, MH., Frohlich, JJ, (1999) Effects of dietary phytosterols on choresterol metabolism and atherosclerosis: clinical and experimental evidence, Am. J. Med., Dic 107(6):588-94
39. Von Holz, RL. Et al, (1998) Beta-sitosterol activates the sphingomyelin cycle and induces apoptosis in LnCap human prostate cancer cells, Nutr Cancer 32(1):8-12
40. Wilt, TJ. et al, (1999) beta-sitosterol for the treatment of bening prostatic hyperplasia. A systematic review, BJU Int Jun 83(9):976-83
41. Bouic, Pj., Lamprecht, JH (1999) Plant sterols and sterolins: a review of their immune-modulating properties, Alter Med Rev Junio 4(3):170-7
42. como 41
43. Gomez, MA. et al, (1999) Study of the topical anti-inflammatory activity of Achillea ageratum on chronic and acute inflammation models, Z. Naturforsch (C) Nov; 54(11):937-41
44. Chang, FR. Et al, Antiplatelet aggregation constituents from Annona purpurea, Grand. Inst. of Natural Prod., Taiwan
45. Gessner, G. (1971) The condensed Chemical Dictionary Eight Ed., Van Nostrand Reinhold Company, New York
46. Nakamura, T et al, (1997) Antimutagenicity of Toshu Tea, Biotechnology Engineering Div. Hibachi:Zosen cor, Hiroshima, Japan
47. Heinicke, R. The Pharmacologically active ingredient of noni, University of Hawaii
48. Kang, SY. et al, (1998) Hepatoprotective activity of scopoletin, a constituent of Solanum lyratum, College of Pharm., Seul Nat. Uni. Korea
49. Duncan, SH. Et al, (1998) Inhibitory activity of gut bacteria against Escherichia coli O157 mediated by dietary plant metabolites, FEMS Microbiol Lett Jul 15; 164(2):283-8
50. Kayser, O., Kolodziej, H. (1997) Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme, Planta Med Dic 63(6):508-10
51. Erazo, S. et al, (1997) Phytochemical and biological study of radal Lomatia hirsute (Proteaceae), J. Ethnopharmacol. Jul 57(2):81-3
52. Farah, MH., Samuelsson, G., (1992) Pharmacologically active phenylpropanoids from Senra incana, Planta Med., Feb 58(1):14-8
53. Huang, L. et al, (1993), Antipyretic and anti-inflammatory effects of Artemisia annua L., Chung Kuo Chung Yao Tsa Chih, Ene 18(1):44-8;63-4
54. Obidoa, O. Obasi, SC., (1991), Coumarin compounds in cassava diets: 2 health implications of scopoletin in gari, Plant Foods Hum Nutr, Jul 41(3):283-9
55. como 55
56. Wardlaw, G., Insel, P., (1990), Perspectives in Nutrition, Times Mirrow/Mosby College Publishing, Boston
57. Lehninger, AL., (1990) Principles of Biochemistry, Worth Publishers New York
58. como 57
59. Davies, S y Stewart, A, Nutritional Medicine, Pan Books, Sydney, London, 1987
60. como 59
61. Osiecki, H. (1990), Nutrients in Profile, Bioconcepts Publishing, Brisbane
62. como 57
63. Liu et Al. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res. 2001; 61(15):5749-56.
64. Kim HG et al. Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells. Fitoterapia. 2004 Jun;75(3-4):261-6
65. Ancolio et Al. Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Phytother Res. 2002; 16(7):646-9.
66. Saludes JP et al. Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn. (Rubiaceae). Phytother Res. 2002; 16(7):683-5.
67. Wang MY, Su C. Cancer preventive effect of Morinda citrifolia (Noni). Ann N Y Acad Sci. 2001 Dec;952:161-8.
68. Wong, DK. Are immune responses pivotal to cancer patient's long term survival? Two clinical case-study reports on the effects of Morinda citrifolia (Noni). Hawaii Med J. 2004 Jun;63(6):182-4.
69. Furusawa et Al. Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumour in mice. Phytother Res. 2003 Dec;17(10):1158-64.
70. Rassaf et al. Circulating NO Pool in Humans. Kidney Blood Press Res. 2005;28(5-6):341-8. Epub 2006 Mar 7.
71. Kim et al. Induction of extracellular matrix synthesis in normal human fibroblasts by anthraquinone isolated from Morinda citrifolia (Noni) fruit. J Med Food. 2005 Winter;8(4):552-5.

Bibliografía adicional recomendada
1. d'Raye, Tonita (1998). Simply Noni - Ancient Health Miracle for Modern Times. Awieca Publishing, Inc.; March 2000, 2nd edition.
2. Elkins, Rita (2002). The Noni Revolution: The Tropical Wonder That Can Fight Disease Boost Energy and Revitalize Your Health. Woodland Publishing; ISBN: 1580543499
3. Fairechild, Diana (2001). Noni: Aspirin of the Ancients. Flyana Rhyme; ISBN: 1892997819
4. Gibbons, Euell (1967). Beachcomber's Handbook. David McKay Co., Inc.
5. Navarre, Isa (2001). 76 Ways to Use Noni Fruit Juice. Direct Source; ISBN: 887938990
6. Solomon, Neil (1998). Noni: Nature's Amazing Healer. Woodland Publishing.
7. Solomon, Neil (2000). Tahitian Noni Juice : How Much, How Often, For What. Direct Source; ISBN: 1887938907
8. Solomon, Neil (1999). The Noni Phenomenon. Direct Source; ISBN: 1887938877
9. Solomon, Neli (1998). Liquid Island Noni (Morinda citrifolia). Woodland Publishing Co, Utah, USA.